TY - JOUR
T1 - Association between telomere-related polymorphisms and the risk of ipf and copd as a precursor lesion of lung cancer
T2 - Findings from the fukuoka tobacco-related lung disease (fold) registry
AU - FOLD Registry Group
AU - Arimura-Omori, Masako
AU - Kiyohara, Chikako
AU - Yanagihara, Toyoshi
AU - Yamamoto, Yuzo
AU - Ogata-Suetsugu, Saiko
AU - Harada, Eiji
AU - Hamada, Naoki
AU - Tsuda, Toru
AU - Takata, Shohei
AU - Shimabukuro, Ikuko
AU - Nagata, Nobuhiko
AU - Yatera, Kazuhiro
AU - Torii, Ryo
AU - Okamoto, Masaki
AU - Fujita, Masaki
AU - Nakanishi, Yoichi
N1 - Funding Information:
We thank the patients, their families, and all of the investigators participating in the Fukuoka Tobacco-Related Lung Disease (FOLD) registry group (all members listed in SSD 5). Funding This work was supported by a grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan as part of a broad-area, network-based project to drive clinical research at Kyushu University Hospital, and partly supported by grants from the Ministry of Education, Science, Sports and Culture, Japan (Y.N.), the Ministry of Health, Labour and Welfare of Japan to the Diffuse Lung Diseases Research Group (N.H.), the Japan Society for the Promotion of Science (a Grant-in-Aid for Scientific Research (B): grant no. 25293143 to C.K. and a Grant-in-Aid for Research Activity start-up: grant no 16H07050 to T.Y.), and the Kanae Foundation for the Promotion of Medical Science (to T.Y.). Ethical statement The study protocol was approved by our institutional review board and research ethics committee (#25-135, #555-00), and all participants provided written informed consent. Supplement and Supporting Data (SSD) SSD 1. Flow diagram of study samples SSD 2. The distributions of selected characteristics among study subjects SSD 3. The allelic frequencies of telomere-related genetic polymorphisms in study subjects SSD 4. The association between the combination of telomere-related genetic polymorphisms and the risk of COPD SSD 5. All of the investigators participating in the Fukuoka Tobacco-Related Lung Disease (FOLD) registry group. Conflict of interest The authors declare that they have no conflict of interest.
Publisher Copyright:
© 2020, Asian Pacific Organization for Cancer Prevention.
PY - 2020/3/1
Y1 - 2020/3/1
N2 - Background: Lung cancer coexisting with idiopathic pulmonary fibrosis (IPF) or chronic obstructive pulmonary disease (COPD) can lead to poor prognosis. Telomere-related polymorphisms may be implicated in the pathogenesis of these three lung diseases. As to elucidate the mechanism of lung cancer via IPF or COPD may enable early detection and early treatment of the disease, we firstly examined the association between telomere-related polymorphisms and the risk of IPF and COPD in a case-control study. Materials and Methods: A total of 572 patients with IPF (n = 155) or COPD (n = 417), who were derived from our on-going cohort study, and controls (n = 379), who were derived from our previous case-control study, were included in this study. Telomerase reverse transcriptase (TERT) rs2736100, telomere RNA component (TERC) rs1881984, and oligonucleotide/oligosaccharide-binding fold containing1 (OBFC1) rs11191865 were genotyped with real-time PCR using TaqMan fluorescent probes. Unconditional logistic regression was used to assess the adjusted odds ratios and 95% confidence intervals. Results: TERT rs2736100 was significantly associated with the risk of IPF; increases in the number of this risk allele increased the risk of IPF (Ptrend = 0.008). Similarly, TERT rs2736100 was associated with the risk of COPD. In regard to the combined action of the three loci, increasing numbers of "at-risk" genotypes increased the risk of IPF in a dose-dependent manner (P trend=0.003). Conclusions: TERT rs2736100 was associated with the risks of both IPF and COPD in a Japanese population. A combination of the "at-risk" genotypes might be important to identify the population at risk for IPF more clearly.
AB - Background: Lung cancer coexisting with idiopathic pulmonary fibrosis (IPF) or chronic obstructive pulmonary disease (COPD) can lead to poor prognosis. Telomere-related polymorphisms may be implicated in the pathogenesis of these three lung diseases. As to elucidate the mechanism of lung cancer via IPF or COPD may enable early detection and early treatment of the disease, we firstly examined the association between telomere-related polymorphisms and the risk of IPF and COPD in a case-control study. Materials and Methods: A total of 572 patients with IPF (n = 155) or COPD (n = 417), who were derived from our on-going cohort study, and controls (n = 379), who were derived from our previous case-control study, were included in this study. Telomerase reverse transcriptase (TERT) rs2736100, telomere RNA component (TERC) rs1881984, and oligonucleotide/oligosaccharide-binding fold containing1 (OBFC1) rs11191865 were genotyped with real-time PCR using TaqMan fluorescent probes. Unconditional logistic regression was used to assess the adjusted odds ratios and 95% confidence intervals. Results: TERT rs2736100 was significantly associated with the risk of IPF; increases in the number of this risk allele increased the risk of IPF (Ptrend = 0.008). Similarly, TERT rs2736100 was associated with the risk of COPD. In regard to the combined action of the three loci, increasing numbers of "at-risk" genotypes increased the risk of IPF in a dose-dependent manner (P trend=0.003). Conclusions: TERT rs2736100 was associated with the risks of both IPF and COPD in a Japanese population. A combination of the "at-risk" genotypes might be important to identify the population at risk for IPF more clearly.
UR - http://www.scopus.com/inward/record.url?scp=85082452287&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85082452287&partnerID=8YFLogxK
U2 - 10.31557/APJCP.2020.21.3.667
DO - 10.31557/APJCP.2020.21.3.667
M3 - Article
C2 - 32212792
AN - SCOPUS:85082452287
SN - 1513-7368
VL - 21
SP - 667
EP - 673
JO - Asian Pacific Journal of Cancer Prevention
JF - Asian Pacific Journal of Cancer Prevention
IS - 3
ER -